ABBOTT & CO MEDICAL LIMITED

💤Zombieactive
10631062 · ltd · incorporated 2017-02-21
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Feb 2025
Net worth
£12.9k
book net assets
Opportunity
71/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: General medical practice activities
Sector: Human health & social work
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and bankable structure.

Opportunity 71/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (1 active, 2 linked, 2 with DOB)
90
Ownership & PSC
1 active PSC(s) of 3 total, 3 with control declared
90
Director network
Network not yet resolved
30
Filing history
25 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
71/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)
Positive net assets
Net assets £12,941

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
£13k
~ YoY
Current Assets
£37k
↑ 494% YoY
Current Liabilities
£0£7k£15k£22k£30k£37kFeb 2024Feb 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)
Metric2025-02-282024-02-29
Total assets£42.5k£27.3k
Current assets£37.2k£6.3k
Net assets£12.9k£12.9k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
4
filings
  • 2 persons-with-significant-control
  • 1 confirmation-statement
  • 1 officers
Counts from Companies House filing history.
Corporate timeline (20 events)Click to expand
  1. 2026-03-14
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  2. 2026-03-12
    📄
    change-person-director-company-with-change-date
    officers · CH01
  3. 2026-03-12
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  4. 2025-11-05
    ABBOTT, Alfie, Dr resigned
    director
  5. 2025-11-05
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  6. 2025-11-05
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  7. 2025-10-17
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  8. 2024-07-24
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  9. 2023-11-27
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  10. 2022-11-29
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  11. 2021-11-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  12. 2020-11-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  13. 2019-11-28
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  14. 2018-11-06
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  15. 2018-02-22
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC01
  16. 2017-11-15
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  17. 2017-02-21
    🏢
    Company incorporated
    As ABBOTT & CO MEDICAL LIMITED
  18. 2017-02-21
    ABBOTT, Rebecca appointed
    director
  19. 2017-02-21
    ABBOTT, Alfie, Dr appointed
    director
  20. 2017-02-21
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

90/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Founder name in company name: Company name contains director surname "ABBOTT" — strong identity link between founder and business.

Succession & seller-readiness

45/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Mrs Rebecca Abbott
Individual · British · DOB 09/1984 · age 42
75100%
75–100%board control75-100% shares · 75-100% voting · board control21/02/2017
2 historic (ceased) PSCs
  • Mr Alfie Daniel Abbottceased 05/11/2025· 25-50% shares
  • Dr Alfie Abbottceased 15/11/2017· 25-50% shares · 25-50% voting · board control

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · CR postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
247LON HEALTHCARE LIMITED
16882538 · est 2025 · no financials extracted
A J FOODS INDIA LIMITED
11878696 · est 2019 · no financials extracted
7y
ACTIVE62 COMPANY LTD
14161124 · est 2022 · no financials extracted
3y
ADAM AESTHETICS LIMITED
13709992 · est 2021 · no financials extracted
4y
ADVANCED PREVENTATIVE MEDICINE LIMITED
17007505 · est 2026 · no financials extracted
ADVANCED TRAINING & HEALTHCARE SERVICES LTD
13740300 · est 2021 · no financials extracted
4y
AE CASTLE LIMITED
17128580 · est 2026 · no financials extracted
AESTHETICS & SKIN BY SALLY LTD
15400702 · est 2024 · no financials extracted
2y
AESTHETICSBYKYRA LTD
16878273 · est 2025 · no financials extracted
AESTHETIX SMILE LIMITED
14660408 · est 2023 · no financials extracted
3y
AFA SUPPORTED LIVING LTD
14660763 · est 2023 · no financials extracted
3y
AFORS WOMEN’S HEALTH LIMITED
12015680 · est 2019 · no financials extracted
6y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2017-02-21
Jurisdictionengland-wales
Primary SIC86210 — General medical practice activities

Registered office

5 Tillingdown Lane
Caterham
CR3 6RU
United Kingdom

Filing status

Accounts
Next due: 2026-11-30
Last made up to: 2025-02-28
Confirmation statement
Next due: 2027-03-06
Last: 2026-02-20

Officers (1 active · 1 resigned)

ABBOTT, Rebecca
director · ~42y · appointed 2017-02-21
View their other companies + combined net worth →
Active
ABBOTT, Alfie, Dr
director · ~39y · appointed 2017-02-21 · resigned 2025-11-05
Resigned

Click a director name to see their full track record across all companies.

Recent filings (25 total)

confirmation-statement-with-updates
confirmation-statement · CS01
2026-03-14
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-03-14
change-person-director-company-with-change-date
officers · CH01
2026-03-12
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-03-12
termination-director-company-with-name-termination-date
officers · TM01
2025-11-05
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2025-11-05
accounts-with-accounts-type-micro-entity
accounts · AA
2025-10-17
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-02-27
accounts-with-accounts-type-micro-entity
accounts · AA
2024-07-24
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-03-01
accounts-with-accounts-type-micro-entity
accounts · AA
2023-11-27
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-02-20
accounts-with-accounts-type-micro-entity
accounts · AA
2022-11-29
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-02-21
accounts-with-accounts-type-micro-entity
accounts · AA
2021-11-30